# GLP-1s and sleep · PepVault guides

Source: https://pepvault.app/guides/glp-1s-and-sleep

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval

Reviewed November 2026 20 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Insomnia is on Saxenda's label only, 2.4% vs 1.7% on placebo. What the labels, trials and reports show for Ozempic, Wegovy, Mounjaro and Zepbound, dreams too.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 20
- **Questions:** 7
- **Compounds:** 3

## The short answer

Insomnia is not listed for Ozempic, Wegovy, Mounjaro or Zepbound; only Saxenda's label lists it, at 2.4% against 1.7% on placebo. Across 86 trials and 133,378 people, sleep problems were no more common on a GLP-1 than on placebo or another drug. No label or trial gives a rate for vivid dreams. The routes the labels support for a bad night are nausea, reflux and low blood sugar.

- Saxenda is the only GLP-1 label that lists insomnia: 2.4% vs 1.7% on placebo.
- In pooled Wegovy trials, sleep complaints were 3.4% on the drug and 3.6% on placebo.
- No label or trial has measured vivid dreams; in diabetes, nightmares can be a sign of low blood sugar at night.
- Reports of sleep and mood complaints cluster in the first weeks, when nausea and reflux peak during the dose steps.

Every number checked at its primary source · Nov 20, 2026 · [20 sources](https://pepvault.app/guides/glp-1s-and-sleep#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Insomnia rests on drug labels, placebo-controlled trials and a meta-analysis of 86 trials; vivid dreams have no label or trial data, only user reports and the maker's statement.

## Does Ozempic, Wegovy, Mounjaro or Zepbound cause insomnia?

Not according to their labels. The word insomnia appears nowhere in the current Ozempic, Wegovy, Mounjaro or Zepbound labels, patient leaflets included[1](https://pepvault.app/guides/glp-1s-and-sleep#source-1) [2](https://pepvault.app/guides/glp-1s-and-sleep#source-2) [3](https://pepvault.app/guides/glp-1s-and-sleep#source-3) [4](https://pepvault.app/guides/glp-1s-and-sleep#source-4). A label's side-effect table lists each **adverse reaction** (an unwanted effect seen in the trials) that happened more often on the drug than on **placebo** (a dummy injection), above a cut-off: 2% for Wegovy, Zepbound and Saxenda, 5% for Ozempic and Mounjaro. The one label that lists insomnia is Saxenda's (liraglutide, an older daily GLP-1): 2.4% of 3,384 people against 1.7% of 1,941 on placebo, a gap of less than one person in a hundred[5](https://pepvault.app/guides/glp-1s-and-sleep#source-5).

The labels do count the effects that can spoil a night: reflux and fatigue, and in diabetes, low blood sugar. The table puts the first two side by side, drug against placebo[1](https://pepvault.app/guides/glp-1s-and-sleep#source-1) [2](https://pepvault.app/guides/glp-1s-and-sleep#source-2) [3](https://pepvault.app/guides/glp-1s-and-sleep#source-3) [4](https://pepvault.app/guides/glp-1s-and-sleep#source-4) [5](https://pepvault.app/guides/glp-1s-and-sleep#source-5).

| Label | Insomnia | Reflux (GERD) | Fatigue |
| --- | --- | --- | --- |
| Ozempic (semaglutide, diabetes) | Not listed | 1.5–1.9% vs 0% | Listed above 0.4%, no placebo rate |
| Wegovy 2.4 mg (semaglutide) | Not listed | 5% vs 3% | 11% vs 5% |
| Mounjaro (tirzepatide, diabetes) | Not listed | 1.7–2.5% vs 0.4% | Not in the placebo table |
| Zepbound (tirzepatide) | Not listed | 4–5% vs 2% | 5–7% vs 3% |
| Saxenda (liraglutide) | 2.4% vs 1.7% | 4.7% vs 1.7% | 7.5% vs 4.6% |

Ranges span the label's dose groups. Wegovy's and Zepbound's fatigue rows include weakness (asthenia). Mounjaro's 10% fatigue comes from a heart-outcomes trial with no placebo group, so it is left out[3](https://pepvault.app/guides/glp-1s-and-sleep#source-3).

<!--promo-->

PepVault's daily check-in on Today takes a tap for nausea and energy, with chips for heartburn and fatigue, and a sleep rating when Recovery is on, so a rough night is logged on the day of the shot it followed. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1s-and-sleep-inline&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault's daily check-in on Today takes a tap for nausea and energy, with chips for heartburn and fatigue, and a sleep rating when Recovery is on, so a rough night is logged on the day of the shot it followed.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What did the trials count for sleep?

Trials record every complaint and file it under MedDRA, the dictionary regulators use to code side effects. In a pooled look at the Wegovy trials STEP 1, 2 and 3 (68 weeks, 3,377 adults), complaints in MedDRA's sleep group, the class that holds insomnia, came up in 3.4% of people on semaglutide 2.4 mg and 3.6% on placebo[6](https://pepvault.app/guides/glp-1s-and-sleep#source-6). In the two-year STEP 5 trial it was 3.9% against 3.3%[6](https://pepvault.app/guides/glp-1s-and-sleep#source-6). The authors call sleep disorders broadly similar between the groups[6](https://pepvault.app/guides/glp-1s-and-sleep#source-6).

The widest view is a 2026 **meta-analysis** (a study that pools other studies) of 86 randomized trials with 133,378 people, GLP-1 drugs against placebo or another treatment. Sleep disorders were no more common on the GLP-1s: a risk ratio of 0.98, where 1.0 means equal, with a range from 0.70 to 1.37[7](https://pepvault.app/guides/glp-1s-and-sleep#source-7). For mental-health problems as a whole, the picture did not change with the drug, the dose or the length of treatment[7](https://pepvault.app/guides/glp-1s-and-sleep#source-7).

## Why do so many people say a GLP-1 ruins their sleep?

Because people do report it, often, even where trials find no gap. In the FDA's reporting system, insomnia was the most reported mental-health complaint with GLP-1 drugs from 2004 to 2023, named 1,198 times across 8,240 reports of a mental-health complaint[8](https://pepvault.app/guides/glp-1s-and-sleep#source-8). Common is not the same as linked. Plain insomnia did not pass that study's signal test; one narrow term did, insomnia put down to a medical condition (75 reports, about twice as often as with other drugs in the database)[8](https://pepvault.app/guides/glp-1s-and-sleep#source-8). A 2026 analysis of 111,105 GLP-1 reports found 16 mental-health terms reported more often than with other diabetes and weight drugs, and none was a sleep term[9](https://pepvault.app/guides/glp-1s-and-sleep#source-9). One older weekly drug, dulaglutide (Trulicity), did show an insomnia signal, reported about three times as often as with other drugs[10](https://pepvault.app/guides/glp-1s-and-sleep#source-10).

Health-record studies, which follow real patients over time, point the other way. In US records of people with type 2 diabetes, semaglutide carried a 14% lower risk of a new insomnia diagnosis over a year than sitagliptin, a gap that did not pass the authors' correction for testing 22 outcomes, and no difference against empagliflozin or glipizide[11](https://pepvault.app/guides/glp-1s-and-sleep#source-11). In adults with obesity, semaglutide carried a lower insomnia risk than naltrexone-bupropion (Contrave) over two years, while tirzepatide carried a 13% higher risk than semaglutide in people without diabetes[12](https://pepvault.app/guides/glp-1s-and-sleep#source-12). Studies like these show links, not causes.

Social media tells the same story. A study of 165 popular TikTok side-effect videos found that every complaint raised in five or more videos was on the package insert, except insomnia[15](https://pepvault.app/guides/glp-1s-and-sleep#source-15). Across Reddit, YouTube and TikTok comments, sleep was the most common mental-health topic, with users describing both worse and better nights[16](https://pepvault.app/guides/glp-1s-and-sleep#source-16).

**Commonly reported:** trouble falling asleep, waking at night and restless evenings in the first weeks or after a dose step, and for others the opposite, deeper sleep without waking hungry. On PepVault's reports pages, which tally what people post on forums and in videos, 2 of 41 semaglutide users named worse sleep; for tirzepatide, 2 of 77 named better sleep and 1 worse.

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Adverse reaction](https://pepvault.app/glossary/adverse-reaction)

## Do GLP-1s cause vivid dreams or nightmares?

No study has measured it. Abnormal dreams and nightmares are in none of the five labels[1](https://pepvault.app/guides/glp-1s-and-sleep#source-1) [2](https://pepvault.app/guides/glp-1s-and-sleep#source-2) [3](https://pepvault.app/guides/glp-1s-and-sleep#source-3) [4](https://pepvault.app/guides/glp-1s-and-sleep#source-4) [5](https://pepvault.app/guides/glp-1s-and-sleep#source-5), no published trial reports a rate, and the two large studies of reports sent to the FDA did not flag them[8](https://pepvault.app/guides/glp-1s-and-sleep#source-8) [9](https://pepvault.app/guides/glp-1s-and-sleep#source-9). The only number comes from the maker: Novo Nordisk told Fox News in 2023 that abnormal dreams were reported at under 0.1 per 100 patient-years in its trials, too rare for the label, and that reports after launch did include them, at a frequency that cannot be estimated[19](https://pepvault.app/guides/glp-1s-and-sleep#source-19).

One known cause does fit, in people with diabetes. Nightmares, crying out in sleep and waking with damp sheets are signs of low blood sugar during the night[17](https://pepvault.app/guides/glp-1s-and-sleep#source-17). The labels say that risk rises when a GLP-1 is taken with insulin or a sulfonylurea, a pill that pushes the body to release insulin[1](https://pepvault.app/guides/glp-1s-and-sleep#source-1) [2](https://pepvault.app/guides/glp-1s-and-sleep#source-2) [3](https://pepvault.app/guides/glp-1s-and-sleep#source-3) [4](https://pepvault.app/guides/glp-1s-and-sleep#source-4). On Zepbound in type 2 diabetes, 10.3% of people also on a sulfonylurea had a low reading, against 2.1% of those not on one[4](https://pepvault.app/guides/glp-1s-and-sleep#source-4). Without diabetes it is rare: 0.3% on Zepbound against none on placebo, in a trial that did not track it closely[4](https://pepvault.app/guides/glp-1s-and-sleep#source-4).

## Why might you sleep worse in the first weeks?

Because that is when the stomach effects peak. Zepbound's label says most nausea, vomiting and diarrhea happened while the dose was being stepped up, and eased over time[4](https://pepvault.app/guides/glp-1s-and-sleep#source-4); Wegovy's says the same of indigestion and reflux[2](https://pepvault.app/guides/glp-1s-and-sleep#source-2). Reflux, acid rising into the food pipe, runs at 4 to 5% on Wegovy and Zepbound against 2 to 3% on placebo[2](https://pepvault.app/guides/glp-1s-and-sleep#source-2) [4](https://pepvault.app/guides/glp-1s-and-sleep#source-4), and the NIH's advice for reflux at night is to eat at least three hours before lying down[18](https://pepvault.app/guides/glp-1s-and-sleep#source-18). Reports of mental-health complaints as a whole also cluster early: a median of 12 days after starting semaglutide and 10 days after tirzepatide, with nearly half in the first 30 days[8](https://pepvault.app/guides/glp-1s-and-sleep#source-8).

Some users tie their nights to hunger, in both directions; no trial has measured it. These steps follow the labels and the NIH's advice on reflux and low blood sugar at night.

1. Note which nights are bad and how many days after your shot they fall.
2. If heartburn or a sour taste wakes you, finish your last meal at least three hours before you lie down[18](https://pepvault.app/guides/glp-1s-and-sleep#source-18).
3. If reflux keeps coming back, raise your head and upper back 6 to 8 inches with a foam wedge or extra pillows[20](https://pepvault.app/guides/glp-1s-and-sleep#source-20).
4. If you take insulin or a sulfonylurea and wake sweaty, shaky or from a nightmare, check your blood sugar then and tell your prescriber, who may lower those drugs[1](https://pepvault.app/guides/glp-1s-and-sleep#source-1) [17](https://pepvault.app/guides/glp-1s-and-sleep#source-17).
5. Bring your notes to your next appointment if poor sleep lasts past the dose steps.

<!--promo-->

Log each bad night as a symptom in PepVault with a severity from 1 to 5 and a note; the log keeps the date, so you can see whether it follows your dose steps. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1s-and-sleep-inline&mt=8)

<!--/promo-->

**When to get help** Waking confused or drenched in sweat while on insulin or a sulfonylurea, or weeks of sleeplessness with low mood, is a reason to call your prescriber soon.

## Can a GLP-1 improve sleep?

In the trials that asked, yes. SURMOUNT-OSA was two 52-week trials of tirzepatide in people with obesity and sleep apnea, and both rated sleep on a standard questionnaire (PROMIS Sleep Disturbance, where a lower score means better sleep). Tirzepatide beat placebo by 2.0 points in the trial without breathing machines and by 3.9 points in the trial with them[13](https://pepvault.app/guides/glp-1s-and-sleep#source-13). An earlier sleep study counted 3.1 points as a meaningful change for one person, but the authors say that bar was not built for comparing group averages, and that meaningful-change thresholds for these questionnaires in sleep apnea are still unsettled[13](https://pepvault.app/guides/glp-1s-and-sleep#source-13).

Outside apnea the evidence is thinner. In a 2026 Turkish study of 78 adults starting semaglutide or tirzepatide, the share with poor sleep on the Pittsburgh Sleep Quality Index fell from 55.1% to 16.7% in three months[14](https://pepvault.app/guides/glp-1s-and-sleep#source-14). It had no comparison group, so it shows a change after starting, not that the drug caused it.

## What about sleep apnea?

Zepbound is the one GLP-1 drug approved for it: its label covers moderate to severe obstructive sleep apnea in adults with obesity[4](https://pepvault.app/guides/glp-1s-and-sleep#source-4). No semaglutide brand carries the approval. Our guide to GLP-1s and sleep apnea covers the trial numbers, how fast it works and what it means for a CPAP machine.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Ozempic (semaglutide) injection, prescribing information. Novo Nordisk. DailyMed, revised June 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)
2. Wegovy (semaglutide) injection and tablets, prescribing information. Novo Nordisk. DailyMed, revised June 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
3. Mounjaro (tirzepatide), prescribing information. Eli Lilly. DailyMed, revised August 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)
4. Zepbound (tirzepatide), prescribing information. Eli Lilly. DailyMed, revised August 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
5. Saxenda (liraglutide), prescribing information. Novo Nordisk. DailyMed, revised February 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143)
6. Wadden TA et al. Psychiatric safety of semaglutide for weight management in people without known major psychopathology: post hoc analysis of the STEP 1, 2, 3, and 5 trials. JAMA Intern Med. 2024. [PubMed 39226070](https://pubmed.ncbi.nlm.nih.gov/39226070/)
7. Han S et al. Association of GLP-1 receptor agonist use with risk of psychiatric disorders: a systematic review and meta-analysis of randomised controlled trials. Diabetes Obes Metab. 2026. [PubMed 41852258](https://pubmed.ncbi.nlm.nih.gov/41852258/)
8. Chen W et al. Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database. Front Endocrinol. 2024. [PubMed 38390214](https://pubmed.ncbi.nlm.nih.gov/38390214/)
9. Moon S et al. Psychiatric safety signals of GLP-1 receptor agonists: a FAERS-based pharmacovigilance study with explainable machine learning. Pharmaceuticals. 2026. [PubMed 42356570](https://pubmed.ncbi.nlm.nih.gov/42356570/)
10. Katranski J et al. Psychiatric adverse events linked to glucagon-like peptide 1 analogues: a disproportionality analysis in American, Canadian and Australian adverse event databases. Int J Clin Pharm. 2025. [PubMed 40522403](https://pubmed.ncbi.nlm.nih.gov/40522403/)
11. De Giorgi R et al. 12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study. EClinicalMedicine. 2024. [PubMed 39764175](https://pubmed.ncbi.nlm.nih.gov/39764175/)
12. Huang YN et al. Neuropsychiatric association of tirzepatide and semaglutide in obesity with and without type 2 diabetes. Commun Med. 2026. [PubMed 42373755](https://pubmed.ncbi.nlm.nih.gov/42373755/)
13. Kanu C et al. Effect of tirzepatide treatment on patient-reported outcomes among SURMOUNT-OSA participants with obstructive sleep apnea and obesity. Sleep Med. 2025. [PubMed 40774158](https://pubmed.ncbi.nlm.nih.gov/40774158/)
14. Kır Y et al. Prospective changes in sleep quality and depressive symptom burden following initiation of GLP-1-based therapies in patients with obesity: a real-world study. J Endocrinol Invest. 2026. [PubMed 42611111](https://pubmed.ncbi.nlm.nih.gov/42611111/)
15. Wantuch GA, Singleton J. TikTok's take on adverse effects for glucagon-like peptide-1 and gastric inhibitory polypeptide receptor agonists. J Am Pharm Assoc. 2025. [PubMed 40049364](https://pubmed.ncbi.nlm.nih.gov/40049364/)
16. Arillotta D et al. GLP-1 receptor agonists and related mental health issues; insights from a range of social media platforms using a mixed-methods approach. Brain Sci. 2023. [PubMed 38002464](https://pubmed.ncbi.nlm.nih.gov/38002464/)
17. Low blood glucose (hypoglycemia). National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). [niddk.nih.gov](https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/low-blood-glucose-hypoglycemia)
18. Eating, diet, and nutrition for GER and GERD. NIDDK. [niddk.nih.gov](https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/eating-diet-nutrition)
19. Rudy M. Ozempic, Wegovy and all those crazy, vivid dreams: is there a connection? Fox News, May 2, 2023 (Novo Nordisk's statement). [foxnews.com](https://www.foxnews.com/health/ozempic-wegovy-crazy-vivid-dreams-connection)
20. Treatment for GER and GERD. NIDDK. [niddk.nih.gov](https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/treatment)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide

Guide · Recovery

### [BPC-157: the human data we have](https://pepvault.app/guides/bpc-157-human-data)

Every published human study of BPC-157: the knee pain, bladder pain and IV safety pilots, what each found, the trials now registered, and how it works.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [Liraglutide Studied range: 0.6–3 mg](https://pepvault.app/peptides/liraglutide)

## Related guides

- Guide · GLP-1s

  ### [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)

  Zepbound is the one drug approved for sleep apnea. The SURMOUNT-OSA results, how fast it works, CPAP, and where semaglutide stands, as of November 2026.

  Read the guide
- Guide · GLP-1s

  ### [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)

  Ozempic and Wegovy side effects from the labels' trials, drug against placebo: nausea and the rest, when they start, how many days they last, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)

  Mounjaro and Zepbound side effects at 5, 10 and 15 mg against placebo, from the labels' trial tables: when they show up, how many stopped, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)

  Do Ozempic, Wegovy, Mounjaro or Zepbound cause depression? The FDA's 2026 review, the labels' warning removed, the trial rates against placebo, and what helps.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)
- [Adverse reaction](https://pepvault.app/glossary/adverse-reaction)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
